FDA Adverse Event Death Summary report: N

XACT CAROTID STENT SYSTEM

MDR report key: 2445104 · Received February 9, 2012

Report

Report Number
2024168-2012-00800
Event Type
Death
Date Received
February 9, 2012
Date of Event
December 20, 2011
Report Date
January 16, 2012
Manufacturer
AV-TEMECULA-CT
Product Code
NIM
PMA / PMN Number
P040038
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
LA, US
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

(B)(4). CONCOMITANT MEDICAL PRODUCTS: (B)(6) 2011=EMBOLIC PROTECTION DEVICE: EMBOSHIELD NAV6; HEPARIN. (B)(6) 2012=ASPIRIN, COUMADIN, PLAVIX. THERE WAS NO REPORTED PRODUCT DEFICIENCY. THE REPORTED PATIENT EFFECTS OF HYPOTENSION, DEATH AND HEMORRHAGE ARE KNOWN POTENTIAL ADVERSE EVENTS AS LISTED IN THE XACT INSTRUCTIONS FOR USE. ALTHOUGH A CONCLUSIVE CAUSE FOR THE REPORTED ADVERSE PATIENT EFFECTS AND RELATIONSHIP TO THE DEVICE, IF ANY, COULD NOT BE DETERMINED; THERE IS NO INDICATION OF PRODUCT QUALITY DEFICIENCY WITH RESPECT TO MANUFACTURE, DESIGN OR LABELING.

Description of Event or Problem · 1

IT WAS REPORTED THAT ON (B)(6) 2011, THE PATIENT UNDERWENT AN XACT STENTING PROCEDURE IN THE LEFT INTERNAL CAROTID ARTERY. THE PATIENT EXPERIENCED HYPOTENSION WHEN THE BALLOON WAS INFLATED PRIOR TO THE STENT PLACEMENT. NEO-SYNEPHRINE 100 MG INTRAVENOUS PUSH WAS GIVEN. THE PATIENT'S BLOOD PRESSURE WAS BASELINE POST PROCEDURE. THE PATIENT WAS DISCHARGED HOME ON (B)(6) 2011. ON (B)(6) 2012, THE PATIENT WAS BROUGHT TO THE EMERGENCY ROOM UNRESPONSIVE AND EXPIRED DUE TO A CATASTROPHIC MULTIFOCAL INTRACEREBRAL HEMORRHAGE CENTERED IN THE LEFT CEREBRAL AREA. THE PATIENT HAD BEEN ON ASPIRIN, COUMADIN AND PLAVIX. THERE WAS NO ADDITIONAL INFORMATION PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 XACT CAROTID STENT SYSTEM CAROTID STENT SYSTEM NIM AV-TEMECULA-CT 1041361

Patients

Seq Age Sex Outcome Treatment
1 86 YR Death